US voters support HIV/Aids relief – will Trump’s cuts backfire in the midterms?
US voters show strong support for the Pepfar program, which aims to combat HIV/Aids and bolster health systems. A recent poll indicates that 74% of likely voters favor funding for Pepfar, with many believing it is a moral obligation to support treatment for those affected. The Trump administration's proposed cuts to the program may face backlash in the upcoming midterm elections as public sentiment remains committed to global health initiatives.
- ▪74% of likely voters support funding for Pepfar, according to a recent poll.
- ▪80% of voters believe there is a moral argument for supporting treatment for those at risk for HIV/Aids.
- ▪The Trump administration has proposed significant cuts to HIV funding, which may impact voter sentiment in the midterms.
Opening excerpt (first ~120 words) tap to expand
Activists demand the Trump administration and Congress fully restore Pepfar programming, in Washington DC on 5 March. Photograph: Brendan Smialowski/AFP via Getty ImagesView image in fullscreenActivists demand the Trump administration and Congress fully restore Pepfar programming, in Washington DC on 5 March. Photograph: Brendan Smialowski/AFP via Getty ImagesUS midterm elections 2026AnalysisUS voters support HIV/Aids relief – will Trump’s cuts backfire in the midterms?Melody SchreiberGlobal Pepfar program has long had Republican leadership and bipartisan support, but initiative is under fire Sun 24 May 2026 08.00 EDTShareUS midterm voters overwhelmingly support Pepfar, an initiative to end HIV/Aids that also has strengthened health systems against other infectious disease threats but has…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Guardian — US.
Discussion
0 commentsMore from The Guardian — US
